Nicotinic receptors, amyloid-beta, and synaptic failure in Alzheimer's disease.
Dysfunctional cholinergic transmission is thought to underlie, at least in part, memory impairment and cognitive deficits in Alzheimer's disease (AD). However, it is still unclear whether this is a consequence of the loss of cholinergic neurons and elimination of nicotinic acetycholine receptors (nAChRs) in AD brain or of a direct impact of molecular interactions of the amyloid-beta (Abeta) peptide with nAChRs, leading to dysregulation of receptor function. This review examines recent progress in our understanding of the roles of nicotinic receptors in mechanisms of synaptic plasticity, molecular interactions of Abeta with nAChRs, and how Abeta-induced dysregulation of nicotinic receptor function may underlie synaptic failure in AD.
Jürgensen
Sofia
S
Institute of Medical Biochemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, 21944-590, Brazil.
Ferreira
Sergio T
ST
D000109:Acetylcholine / Q000378:metabolism; D000544:Alzheimer Disease / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D000818:Animals; D001921:Brain / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D002799:Cholinergic Fibers / Q000378:metabolism / Q000473:pathology; D006801:Humans; D009410:Nerve Degeneration / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology; D009473:Neuronal Plasticity / Q000502:physiology; D011978:Receptors, Nicotinic / Q000378:metabolism*; D013569:Synapses / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D009435:Synaptic Transmission / Q000502:physiology
D016229:Amyloid beta-Peptides; D011978:Receptors, Nicotinic; D000109:Acetylcholine
Brain Res Mol Brain Res. 1998 Dec 10;63(1):72-8
9838051
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6448-53
9600986
Biochem Pharmacol. 2007 Oct 15;74(8):1120-33
17689497
J Neurosci. 1993 Jun;13(6):2680-8
8501532
Psychopharmacology (Berl). 1992;108(4):443-7
1410156
J Neurosci. 2007 Jan 24;27(4):796-807
17251419
Acta Neurol Scand Suppl. 1993;149:62-5
8128843
Nat Rev Neurosci. 2007 Feb;8(2):101-13
17237803
Lancet Neurol. 2008 Sep;7(9):812-26
18667359
Br J Pharmacol. 2005 Dec;146(7):964-71
16184187
Science. 2002 Oct 25;298(5594):789-91
12399581
J Neurosci. 2003 Jul 30;23(17):6740-7
12890766
J Neurosci. 2006 Sep 20;26(38):9780-93
16988049
Nat Rev Neurosci. 2002 Feb;3(2):102-14
11836518
Alzheimers Dement. 2006 Jan;2(1):43-55
19595855
IUBMB Life. 2007 Apr-May;59(4-5):332-45
17505973
J Biol Chem. 2005 Sep 2;280(35):31085-90
15987688
J Neurosci. 2001 Jan 1;21(1):RC120
11150356
Annu Rev Pharmacol Toxicol. 2007;47:699-729
17009926
J Alzheimers Dis. 2002 Oct;4(5):349-55
12446967
Neurobiol Aging. 2008 Sep;29(9):1334-47
17403556
Prog Neurobiol. 2007 May;82(1):11-32
17428603
Brain Res. 1987 Dec 8;436(1):62-8
3690354
Biochem Biophys Res Commun. 2006 Dec 8;351(1):259-65
17054909
Psychopharmacology (Berl). 1993;111(4):508-11
7870995
J Neurosci. 2003 Apr 15;23(8):3176-85
12716925
J Neurosci. 1997 Jan 15;17(2):576-85
8987780
J Neurosci. 2005 Nov 30;25(48):11061-70
16319306
Brain Res. 2007 Nov 28;1182:82-9
17935702
J Biol Chem. 2004 Sep 3;279(36):37842-51
15234980
Physiol Rev. 2009 Jan;89(1):73-120
19126755
Learn Mem. 2004 Jan-Feb;11(1):60-9
14747518
Ann Neurol. 1978 Jun;3(6):471-3
209723
Neurobiol Dis. 2005 Nov;20(2):187-98
16242627
J Neurophysiol. 2002 Jan;87(1):548-57
11784770
Neuropharmacology. 2006 Feb;50(2):254-68
16324726
Science. 2002 Jul 19;297(5580):353-6
12130773
Science. 1992 Apr 10;256(5054):184-5
1566067
J Comp Neurol. 1989 Jun 8;284(2):314-35
2754038
Alzheimers Dement. 2007 Jul;3(3):186-91
19595937
Drug Saf. 1998 Dec;19(6):465-80
9880090
J Neurophysiol. 2003 Jun;89(6):2917-22
12611941
J Neurochem. 2009 May;109 Suppl 1:153-9
19393022
Nat Med. 2004 Jul;10 Suppl:S2-9
15272266
Nat Med. 2008 Aug;14(8):837-42
18568035
Nature. 2002 Apr 4;416(6880):535-9
11932745
Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13541-6
8942969
FASEB J. 2008 Jan;22(1):246-60
17720802
J Alzheimers Dis. 1999 Nov;1(4-5):207-19
12214120
Ann N Y Acad Sci. 1996 Jan 17;777:57-64
8624127
Front Biosci. 2007 Sep 01;12:5030-8
17569627
Nat Rev Mol Cell Biol. 2007 Feb;8(2):101-12
17245412
Eur J Pharmacol. 2008 May 6;585(1):109-18
18377893
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1971-6
19188609
Brain Res Bull. 2008 Sep 30;77(2-3):84-90
18602971
J Neurosci. 2001 Oct 15;21(20):7993-8003
11588172
Biochem Biophys Res Commun. 1984 May 16;120(3):885-90
6375662
Eur J Neurosci. 2006 Dec;24(11):3109-18
17156372
Nat Neurosci. 2005 Aug;8(8):1051-8
16025111
Neuron. 2001 Jul 19;31(1):131-41
11498056
Nature. 1996 Oct 24;383(6602):713-6
8878480
Ann Pharmacother. 1999 Apr;33(4):441-50
10332536
Eur J Pharmacol. 2000 Mar 30;393(1-3):215-22
10771016
Neuroscience. 1999;88(3):755-64
10363815
J Biol Chem. 2002 Jul 12;277(28):25056-61
11983690
J Biol Chem. 2008 Apr 4;283(14):9359-68
18234671
Brain Res. 1999 Oct 30;846(1):137-43
10536221
J Biol Chem. 2007 Apr 13;282(15):11590-601
17308309
Brain Res. 1992 Nov 20;596(1-2):142-8
1467980
J Pharmacol Sci. 2003 Oct;93(2):180-7
14578586
IUBMB Life. 2007 Apr-May;59(4-5):316-21
17505971
Curr Med Chem. 2008;15(24):2433-55
18855672
J Neurophysiol. 2003 Nov;90(5):3130-6
12890800
J Neurosci. 2004 Nov 10;24(45):10191-200
15537891
J Comp Neurol. 1985 Sep 8;239(2):237-46
4044938
Lancet. 1976 Dec 25;2(8000):1403
63862
Br Med J. 1978 Nov 25;2(6150):1457-9
719462
Nat Rev Neurosci. 2007 Jun;8(6):413-26
17514195
J Neurochem. 2000 Sep;75(3):1155-61
10936198
Neurotherapeutics. 2008 Jul;5(3):433-42
18625455
Prog Neurobiol. 2000 Feb;60(2):109-37
10639051
J Physiol. 2003 Feb 15;547(Pt 1):147-57
12562926
J Neurosci. 1993 Feb;13(2):596-604
7678857
Synapse. 2006 Jun 15;59(8):491-501
16565963
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4734-9
11274373
J Neurosci. 2009 Jan 28;29(4):918-29
19176801
J Neurosci. 2008 Dec 31;28(53):14537-45
19118188
Neuroscience. 2003;122(2):515-20
14614915
Eur J Neurosci. 1999 Jul;11(7):2551-65
10383644
Neuron. 2006 Dec 7;52(5):831-43
17145504
J Mol Neurosci. 2005;27(1):13-21
16055943